Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
QwjTn5FP1mMSnXYX
Listen
